Sionna Therapeutics, Inc. (SION) Rises on Biotech AdvancesSionna Therapeutics, Inc.BATS:SIONtraderspro_chartsSionna Therapeutics, Inc. (SION) is a biotechnology company focused on developing innovative therapies to treat cystic fibrosis (CF) by directly targeting the underlying genetic defect. Its pipeline leverages small-molecule modulators to restore function to the CFTR protein, aiming to improve lung function and quality of life for patients. Sionna’s growth is fueled by advancing clinical studies, partnerships in rare disease research, and a mission to redefine CF treatment at the molecular level. On the chart, a confirmation bar with rising volume highlights bullish momentum. The price has entered the momentum zone after breaking above the .236 Fibonacci level. A trailing stop can be set just below this Fibonacci line using the Fibonacci snap tool, helping traders protect gains while leaving room for continued upside potential.